BeStock  
Stocks › Biotechnology › IMMX

Immix Biopharma IMMX

US equityMarket cap rank #3420Biotechnology
$9.49 −$0.15 (-1.56%)
Pre-market · Oct 8, 8:50 am ET · After hours $9.49 0.00%
Open$9.50
Prev close$9.64
Day range$9.40 – $9.69
Volume1.38M
Market cap$788.42M
P/E (TTM)–
Dividend yield–

IMMX Stock News

Headlines matching Immix Biopharma or the IMMX ticker, most recent first.

  • A Quick Look at Today's Ratings for Immix Biopharma(IMMX.US), With a Forecast Between $24 to $30Market news · 30 Sep 2026 · Direct mention
  • Mizuho Securities Maintains Immix Biopharma(IMMX.US) With Buy Rating, Raises Target Price to $26 PositiveMarket news · 15 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Immix Biopharma(IMMX.US) With Buy Rating, Maintains Target Price $26Market news · 13 Sep 2026 · Direct mention
  • LifeSci Capital Maintains Immix Biopharma(IMMX.US) With Buy Rating, Raises Target Price to $26 PositiveMarket news · 10 Sep 2026 · Direct mention
  • BofA Securities Maintains Immix Biopharma(IMMX.US) With Buy RatingMarket news · 14 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Immix Biopharma(IMMX.US) With Buy Rating, Maintains Target Price $15Market news · 12 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Immix Biopharma(IMMX.US) With Buy Rating, Cuts Target Price to $19 NegativeMarket news · 11 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Immix Biopharma(IMMX.US) With Buy Rating, Raises Target Price to $25 PositiveMarket news · 10 Aug 2026 · Direct mention
  • Needham Maintains Immix Biopharma(IMMX.US) With Buy Rating, Maintains Target Price $21Market news · 10 Aug 2026 · Direct mention
  • Needham Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $21Market news · 22 Jul 2026 · Direct mention
  • BofA Securities Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $27Market news · 18 Jun 2026 · Direct mention
  • LifeSci Capital Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $19Market news · 17 Jun 2026 · Direct mention
  • Analysts' Opinions Are Mixed on These Healthcare Stocks: Biohaven Ltd. (BHVN) and Immix Biopharma (IMMX)TipRanks · 27 May 2026 · Direct mention
  • H.C. Wainwright Maintains Immix Biopharma(IMMX.US) With Buy Rating, Raises Target Price to $20 PositiveMarket news · 22 May 2026 · Direct mention
  • Citizens JMP Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $23Market news · 9 Mar 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on IMMX.

Leave a comment

Scroll to Top